SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing
2 references·16 citing·23 second hop
Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Detection of HIV-1 and HCV Infections amo…Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Current prevalence and incide…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Prevention of transfusion-transmitted infections (2019)Prevention of transfusion-tra…Seroprevalence and incidence of transfusion‐transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa (2011)Seroprevalence and incidence …Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Donor Testing and Risk: Curre…Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Transfusion‐associated infect…Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevalence, incidence, and re…The risk of transfusion‐transmitted infections in sub‐Saharan Africa (2009)The risk of transfusion‐trans…Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Impact of individual‐donation…Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. (2008)Multicenter evaluation of ind…Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Impact of nucleic acid testin…Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)Experience of German Red Cros…Transfusion-transmitted infections (2007)Transfusion-transmitted infec…Current Risks of Transfusion-Transmitted Agents: A Review (2007)Current Risks of Transfusion-…Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services (2007)Current incidence and estimat…Hepatitis B virus blood screening: unfinished agendas (2006)Hepatitis B virus blood scree…Assessing the impact of HBV NAT on window period reduction and residual risk (2006)Assessing the impact of HBV N…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating…Hepatitis B Virus Antibody in Blood Donors and the Occurrence of Non-A, Non-B Hepatitis in Transfusion Recipients (1984)Emerging infectious disease agents and their potential threat to transfusion safety (2009)Modeling the transmission risk of emerging infectious diseases through blood transfusion (2012)Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk (2017)Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low‐resource settings (2017)The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)Quantitative estimate of the risks and benefits of possible alternative blood donor deferral strategies for men who have had sex with men (2009)Blood Donation, Deferral, and Discrimination: FDA Donor Deferral Policy for Men Who Have Sex With Men (2010)Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus (2014)Standards for blood banks and transfusion services. (1977)Transfusion-transmissible infections among blood donors in Kathmandu, Nepal (2009)Seroprevalence of transfusion transmissible infections among blood donors in a tertiary care hospital of Andhra Pradesh (2010)Seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north India (2015)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Risk factors for human immunodeficiency virus infection among Brazilian blood donors: a multicentre case–control study using audio computer‐assisted structured interviews (2013)The Use of Rapid Diagnostic Tests for Transfusion Infectious Screening in Africa: A Literature Review (2014)Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016 (2020)Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions (2009)Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India (2013)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐ and low‐middle‐income countries (2020)HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern (2020)Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions (2021)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited

Cited by

  • 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
  • 2019Prevention of transfusion-transmitted infections295 cited
  • 2010Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing287 cited
  • 2007Transfusion-transmitted infections264 cited
  • 2010Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress201 cited
  • 2011Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations198 cited
  • 2008Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus189 cited
  • 2007Current Risks of Transfusion-Transmitted Agents: A Review162 cited
  • 2009The risk of transfusion‐transmitted infections in sub‐Saharan Africa160 cited
  • 2007Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services154 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2009Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa139 cited
  • 2006Assessing the impact of HBV NAT on window period reduction and residual risk114 cited
  • 2008Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey99 cited
  • 2006Hepatitis B virus blood screening: unfinished agendas94 cited
  • 2011Seroprevalence and incidence of transfusion‐transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa93 cited
  • 2008Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.73 cited